Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-OHPC for Prevention of Preterm Delivery in Twins
NCT00141908Phase 2Completed
- Sponsor
- American University of Beirut Medical Center
- Start
- Oct 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyprogesterone caproate in preterm birth, sponsored by American University of Beirut Medical Center. Started Oct 2006; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT00141908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141908.